Cryptococcus neoformans is an encapsulated yeast that causes disease mainly in 31 immunosuppressed hosts. It is considered a facultative intracellular pathogen because 32 of its capacity to survive and replicate inside phagocytes, especially macrophages. This 33 capacity is heavily dependent on various virulence factors, particularly the 34 glucuronoxylomannan (GXM) component of the polysaccharide capsule, that render the 35 non-or poorly-activated macrophage ineffective against phagocytosed yeast. Strategies 36 utilized by macrophages to prevent this scenario include pyroptosis (a rapid highly 37 inflammatory cell death) and vomocytosis (the expulsion of the pathogen from the 38 intracellular environment without lysis). Inflammasome activation in phagocytes is 39 usually protective against fungal infections, including cryptococcosis. Nevertheless, 40 recognition of C. neoformans by inflammasome receptors requires specific changes in 41 morphology or the opsonization of the yeast, impairing a proper inflammasome 42 function. In this context, we analyzed the impact of molecules secreted by C. 43 neoformans B3501 strain and its acapsular mutant Δcap67 in an inflammasome 44 activation in vitro model. Our results showed that conditioned media derived from 45 B3501 was capable of inhibiting inflammasome dependent events (i. e. IL-1β secretion 46 and LDH release via pyroptosis) more strongly than conditioned media from Δcap67, 47 57 58 59 2 60 Author's Summary 61
regardless of GXM presence. We also demonstrated that macrophages treated with 48 conditioned media were less responsive against infection with the virulent strain H99, 49 exhibiting lower rates of phagocytosis, increased fungal burdens and enhanced 50 vomocytosis. Moreover, we showed that the aromatic metabolite DL-Indole-3-lactic acid 51 (ILA) was present in B3501's conditioned media and that this fungal metabolite is 52 involved in the regulation of inflammasome activation by C. neoformans. Overall, the 53 results presented show that conditioned media from a wild-type strain can inhibit an 54 important recognition pathway and subsequent fungicidal functions of macrophages, 55 contributing to fungal survival in vitro and suggesting that this serves as an important 56 role for secreted molecules during cryptococcal infections.
Introduction 74
Cryptococcus neoformans is a fungal pathogen that primarily affects 75 immunocompromised patients with acquired immunodeficiency syndrome (AIDS) [1] . C. 76 neoformans is responsible for over 180 thousand deaths yearly worldwide [2] . Human 77 infection is usually initiated by the inhalation of environmental spores or yeasts that are 78 frequently present in avian droppings [3] [4] [5] [6] [7] . Once in the lung, the fungus is usually 79 cleared from the host or survives within granulomas. In the context of 80 immunosuppression, primary acquisition or relapse of previously contained yeast can 81 result in disseminated disease, especially involving the central nervous system [5, 8, 9] . 82 The ability of C. neoformans to remain viable and survive inside the host is 83 dependent on its many virulence factors, which allow the fungus to modulate and evade 84 the immune response [10, 11] . These virulence factors include enzymes (laccase, urease, 85 phospholipases, proteases and others) that can be secreted freely or encapsulated in 86 extracellular vesicles [10, [12] [13] [14] , melanin deposition in the cell wall [14, 15] and the 87 formation of a polysaccharide, which is considered the most important of these factors 88 [16] [17] [18] . Glucuronoxylomannan (GXM) is the most prevalent of these capsular 89 polysaccharides, facilitating C. neoformans resistance against phagocytosis and 3 90 suppressing various immune responses [19] [20] [21] [22] [23] [24] [25] [26] . Altogether these virulence factors 91 enable this fungus to effectively survive and thrive as a facultative intracellular 92 pathogen, particularly within macrophages [27] [28] [29] [30] [31] [32] [33] . In fact, depletion of alveolar 93 macrophages in mice is associated with a worse prognosis, indicating that they are 94 coopted by C. neoformans during pathogenesis to facilitate fungal growth and 95 dissemination [34] . Phagocytic cells that are unable to kill intracellular yeast cells can 96 return fungal cells to the extracellular environment, either through a non-lytic 97 exocytosis called vomocytosis [35] [36] [37] [38] or a rapid, highly inflammatory and 98 inflammasome dependent cell death referred to as pyroptosis [39] [40] [41] . 99 The inflammasome is an intracellular multi-protein complex that usually requires 100 an intracellular damage-associated molecular pattern (DAMP) for its oligomerization 101 and proper function [42] . The canonical activation step requires the engagement of an 102 intracellular receptor from the NOD-like receptors (NLRs) or AIM2-like receptors (ALRs) 103 family, an adaptor protein ASC and the cleavage of procaspase-1. Although some cell 104 types are able to activate inflammasome pathways from basal expression levels, most 105 of them require extracellular signaling, promoted by membrane bound pattern- 106 recognition receptors, to initiate inflammasome activation [43] . The activated caspases 107 in this context are responsible for the previously described pyroptosis cell death and, 108 most importantly, for the processing of interleukin (IL)-1β and IL-18, important 109 mediators of inflammatory Th1/Th17 driven responses [44] . 110 Among the receptors associated with inflammasome oligomerization, NLRP3 is 111 one of the best described and well-characterized in fungal recognition [45] . This 112 receptor is involved in the recognition of various fungal species, between yeast and 113 hyphal forms, and opportunistic and primary pathogens [46] [47] [48] [49] [50] [51] . The activation of 114 NLRP3 is usually dependent on one or more intracellular stress signals (i. e. potassium 115 efflux; mitochondrial ROS production and cathepsin release), which are associated with 116 the interaction between the host cell and the fungus [42, 45] . NLRP3 activation in 117 response to C. neoformans only occurs when the yeast is in specific conditions such as 118 biofilms [52], lacking capsule [53] , or opsonized prior to phagocytosis [54] . Moreover, 119 all three classical stress signals are required to activate NLRP3 during these interactions 120 [52] . Notably, mice lacking NLRP3 or ASC are more susceptible to cryptococcal infection 121 with encapsulated yeast cells, whereas infection with acapsular yeast cells results in 4 122 higher fungal burdens in the lungs in NLRP3 knockout mice [52, 53] . Likewise, 123 susceptibility to cryptococcal infection has been also observed in murine knockout 124 models for IL-1β and IL-18 receptors [55, 56] . 125 Different strains of C. neoformans elicit variable IL-1β induction, especially in in 
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Exopolysaccharide incorporation on acapsular mutant does not impair macrophage 137 inflammasome activation. 138 As described [53,54], C. neoformans mutants lacking GXM expression and proper 139 capsule formation triggered inflammasome activation more effectively than compared 140 to wild type encapsulated yeast cells ( Fig 1A) . However, we found that ∆cap67 141 encapsulated with exo-PS induced significantly more IL-1β secretion compared to the 142 wild type B3501 ( Fig 1B) . This result suggested that the presence of GXM on the yeast 143 surface by itself was not sufficient to explain the differences in inflammasome activation 144 observed between acapsular mutants and their wild type counterparts. 145 CM35, but not CMCAP or minimal media, reduces IL-1β secretion. 146 Since many of the virulence factors presented by C. neoformans are secreted 147 [10,15], we evaluated whether components released by the fungus were able to inhibit 148 inflammasome canonical activation, induced by the combination of LPS and nigericin 149 treatments ("activated" macrophages and dendritic cells). The addition of CM35 to 150 activated macrophages and dendritic cells significantly reduced the secretion of IL-1β by 5 151 these cells, while CMCAP, MM and glycine inhibited IL-1 β secretion to a lesser degree 152 (Fig 2A and 2B , S1A). Interestingly, CM35, CMCAP and MM did not reduce the secretion 153 of TNF-α ( Fig 2C and 2D , S1B), even if added before LPS priming (S1C Fig) . The specific 154 interference of conditioned media in the secretion of IL-1β, an inflammasome 155 dependent cytokine, but not in TNF-α, an inflammasome-independent cytokine, 156 indicates that the canonical inflammasome pathway is being inhibited. The reduction in 157 IL-1β observed with CMCAP and minimal media is likely explained by the presence of 158 glycine, since this component is present in minimal medium and exhibits the same 159 interference in the cytokine secretion (Fig 2A) . When primed with LPS and challenged 160 with the acapsular strain ∆cap67, macrophages still show a marked reduction in IL-1β 161 levels in the presence of CM35, while in these conditions MM and glycine did not affect 162 the secretion of this cytokine (Fig 2E) , indicating that CM35 is able to affect the 163 inflammasome pathway in the context of different activators. To investigate the 164 molecular identity of the component causing effects in the inflammasome, the 165 conditioned and minimal medium were filtered to obtain fractions of different sizes. Of 166 the fractions from CM35, all fractions, except the fraction between 100 and 10 kDa 167 inhibited IL-1β secretion ( Fig 2F) , indicating that molecules below the 10 kDa range were 168 necessary for the effect seen with CM35 treatment. Since the greatest effect was 169 achieved with the fractions below 1kDa, the next assays were conducted utilizing this 170 small size fraction (1KDa-CM35), unless stated otherwise. 171 CM35 inhibits caspase-1 activation, promoting pro-IL-1β accumulation and cell death 172 inhibition. 173 Canonical inflammasome activation triggers various processes in the cell, 174 including but not limited to IL-1β maturation and secretion. In that context, we analyzed 175 other cell processes related to inflammasome activation that might be altered in 176 macrophages interacting with CM35, while primed with LPS and nigericin, such as cell 177 death via pyroptosis and intracellular pro-IL-1β cleavage. The results of the 178 measurements of cell death by LDH release followed the same pattern seen in IL-1β 179 secretion ( Fig 3A) . The fact that both stimuli, LPS and nigericin, were necessary for LDH 180 release confirms cell death via inflammasome activation in our experimental conditions. 181 When macrophages were treated with CM35, LDH release was largely abrogated, while 6 182 treatment with CMCAP or MM resulted in a smaller inhibition of macrophage cell death 183 ( Fig 3A) , which again is likely partly explained by the presence of glycine in the media 184 [57]. Regarding pro-IL-1β, the results showed that macrophages must be primed with 185 LPS for this cytokine production and that the presence of nigericin does not alter its 186 intracellular levels, indicating a constant production of this inactive cytokine in our 187 model. (Fig 3B) . When treated with CM35, primed macrophages exhibited an increase 188 in intracellular pro-IL-1β protein, while cells treated with MM did not ( Fig 3B) . 189 Surprisingly, treatment with CMCAP also induced a high accumulation of intracellular 190 pro-IL-1β ( Fig 3B) . This might be explained by the fact that CMCAP was the only 191 treatment able to induce pro-IL-1β production without LPS. In fact, both conditioned 
CM35 impacts phagocytic capacity and extrusion events in interactions between
212 macrophages and C. neoformans. 213 A potent pro-inflammatory polarization is important for a protective response 214 against cryptococcosis [58] . Given that IL-1β is one of the key cytokines associated with 215 heightened inflammation, we analyzed if CM35 treatment caused a functional 216 impairment of macrophages when infected with C. neoformans. We initially evaluated 217 intracellular fungal burdens in macrophages when yeast cells were added at the same 218 time as conditioned media or minimal media. Interestingly, none of the treatments 219 impacted fungal intracellular growth in primed macrophages ( Fig 4A) . However, when 220 macrophages were primed for 18 h with conditioned medium, CM35 promoted a 221 significant reduction in the phagocytic capacity presented by macrophages, with or 222 without LPS stimuli ( Fig 4B) . 223 Another important aspect of macrophage-Cryptococcus interaction that we 224 analyzed was vomocytosis in the presence of CM35. Parental H99 cells were labelled 225 with calcofluor white to differentiate parent from daughter yeast cells (daughter cells 226 form de novo cell walls and are thus not labeled). Macrophages were concomitantly 227 exposed to CM35 and infected with H99 strain. Yeast cells with high fluorescence were 228 measured to exclude cells that appeared via budding. We observed that groups 229 containing macrophages treated with CM35 had a higher content of extracellular parent 230 yeast cells compared to the groups containing untreated macrophages ( Fig 4D and 4F ). 231 The difference between groups starts to increase at 12 h of infection (p>0.001), 232 increasing once again after 24 h. Corroborating this data, intracellular parent yeast cells 233 number showed an inverse pattern, reducing after 12 h of infection in the groups treated 234 with CM35 ( Fig 4E and 4G ). Knowing that macrophages treated with CM35 present an 235 equal rate of cell death when compared to untreated cells ( Fig 3A) , the increase of To further characterize the conditioned medium, CM35 was submitted to 260 autoclaving and separated into polar and nonpolar soluble fractions. Autoclaved CM35 261 retained its inhibitory properties and the polar fraction, but not the nonpolar, also 262 retained this property ( Fig 5A) . Raw CM35 was also treated with various proteases 263 before its addition to primed macrophages. None of the treatments eliminated the 264 inhibition promoted by the conditioned media, and the proteases themselves also did 265 not significantly alter IL-1β secretion ( Fig 5B) . Overall, the analysis showed that a small, individually revealed that ILA was the most inhibitory to the inflammasome ( Fig 6A) , 297 while not affecting TNF-α secretion ( Fig 6B) . Most notably, ILA alone significantly 298 reduced caspase-1 activation to levels similar to that achieved with CM35 ( Fig 6C) . 299 Interestingly, ILA did not reduce caspace-1 activation when macrophages were activated 10 300 with Δcap67 infection instead of nigericin ( Fig 6D) . This result suggests that ILA may 301 participate in CM35 inhibition properties, but that it is not the sole molecule responsible 302 for this capacity. Hence, it is possible that CM35 inhibitory properties are due to a 303 combination of molecules. At this point we identify ILA as an immunomodulatory 304 metabolite produced by C. neoformans. Gas chromatography-mass spectrometry analysis. 658 Metabolites from conditioned culture media were derivatized as described [95] . 659 Ketone groups of metabolites were derivatized by adding with 20 μL of 30 mg/mL 660 methoxyamine in pyridine (Sigma-Aldrich) and incubating at 37°C for 90 minutes with 
